Atlas.
Sign inStart free trial
PACBNASDAQ · US

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Technology · Laboratory Analytical Instruments

TechnologyLaboratory Analytical Instruments
CEO
Christian O. Henry
Founded
—
IPO Date
—
HQ
Menlo Park, CA, United States
Exchange
NASDAQ
Employees
n.a.

Share Price Performance

$1.74 ▼ 5.4%
Last (1 Jul 2026) · $2
Period High · $2.67
Period Low · $1.12
52W: $1.12 – $2.67

Key Metrics

Share Price
$1.74
+3.6% today
Market Cap
$525M
P / E
—
EV / Revenue
2.9x
Revenue Growth
+3.9%
year-on-year
Gross Margin
+28.6%
Enterprise Value
$462M
52W High
$2.67
52W Low
$1.12
Avg Volume
6.3M
daily

Sources: SEC filings · Market data as of Jul 6, 2026

Shareholders' Structure
13 known institutional holders·$64M total on record·2026-Q1
BlackRock, Inc.
8.4%·$33M
Geode Capital Management, LLC
2.3%·$9M
State Street Corp
2.0%·$8M
Renaissance Technologies LLC
0.8%·$3M
Northern Trust Corp
0.7%·$3M
Bank Of America Corp
0.6%·$2M
Invesco Ltd.
0.5%·$2M
Goldman Sachs Group Inc
0.3%·$1M
Dimensional Fund Advisors LP
0.3%·$1M
Point72 Asset Management, L.P.
0.1%·$377,124
Price T Rowe Associates Inc
0.1%·$249
Jpmorgan Chase & Co
0.0%·$174,515
Fmr LLC
0.0%·$48,818
Free Float
83.9%

Sources: SEC filings

Notes: % shown as share of total shares outstanding · Free float = shares outstanding minus all known 13F institutional holdings

What Atlas covers for PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
OverviewPACIFIC BIOSCIENCES OF CALIFORNIA, INC. share price history (10 years), key market statistics, and institutional shareholder structure from SEC 13F-HR filings.Business ModelHow PACIFIC BIOSCIENCES OF CALIFORNIA, INC. generates revenue — product and service segments, geographic breakdown, key operating metrics, and 10-year business evolution sourced from SEC filings.FinancialsPACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s complete financial history — 10 years of annual revenue, gross margins, operating income, net income, EPS, and free cash flow from SEC filings, plus 12 quarters of quarterly results.Management QualityPACIFIC BIOSCIENCES OF CALIFORNIA, INC. executive team profiles, insider buying and selling from SEC Form 4, earnings call transcripts, and a track record of guidance delivery vs actual results.Risk FactorsPACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s annual risk disclosures from SEC filings — full text, 5-year evolution showing how risks have shifted, and year-on-year delta highlighting new and removed risks.NewsAI-synthesised news digest for PACIFIC BIOSCIENCES OF CALIFORNIA, INC., updated regularly with key developments, earnings updates, product announcements, and material company events.SentimentInvestor sentiment for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. aggregated from X.com, Reddit, and Hacker News — discussion themes, Bull and Bear signals, and community analysis.Valuation & PeersPACIFIC BIOSCIENCES OF CALIFORNIA, INC. valuation multiples — P/E, EV/Revenue, EV/EBITDA — compared against a curated set of industry peers using live data from SEC filings. Custom peer selection available.DCF BuilderBuild a discounted cash flow model for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. with 10 years of pre-filled revenue, margins, and cash flow data from SEC filings. Adjust growth rates, WACC, and terminal assumptions.Atlas AnalysisAtlas AI research synthesis for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. — business model, financial health, management quality, risk profile, and institutional ownership, grounded exclusively in SEC filings.

Unlock the full analysis

9-tab institutional research sourced directly from SEC filings. No tips, no scores — the same process professional investors use.

7-day free trial · Plus & Pro · No charge during trial